Plain-English translation of NCT07293260 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This trial is testing a medication called to see if it can reduce the amount of plaque building up in your heart arteries. Plaque buildup narrows arteries and can lead to heart attacks and other serious problems. The study will compare people who receive the medication to those who receive a placebo (a dummy injection with no active drug) to see if the medication actually works.
Many people have a blood marker called lipoprotein(a) that puts them at higher risk for heart disease, even when they're taking other heart medications. Researchers want to know if this new treatment can help reduce plaque in the arteries of these high-risk patients and potentially prevent future heart problems.
You likely qualify if…
You likely don't qualify if…
You will come to the clinic for screening tests, including a heart imaging scan (CT angiography) to look at your arteries. If you qualify, you'll be randomly assigned to receive either the new medication or a placebo injection under your skin every 12 weeks. You'll have follow-up visits with heart scans and blood tests to monitor how well the treatment is working and check for any side effects.
AI-generated summary from trial data · Jul 16, 2026 · Not medical advice
United States